Advertisement

Topics

Health 2.0 Accelerator Company Profile

06:23 EDT 21st September 2017 | BioPortfolio

H2A is a nonprofit organization whose goal is to advance consumer-centric health care by driving integration of technology and the consumer experience across a network of new and established technology companies and health care organizations by developing common understanding of consumer value and promoting trusted use of Health 2.0 technology solutions; removing integration barriers that limit mutually beneficial collaborative business opportunities, facilitating integration of Health 2.0 technology solutions in "traditional" health care environments and with provider-centric technologies, encouraging an appropriate balance of consumer protection and commercial opportunity for Health 2.0 technology solutions, as well as financial incentives that encourage data liquidity; and enabling the development of revenue sharing arrangements and mutually beneficial business models. For more information, go to: www.health2accelerator.org


News Articles [2429 Associated News Articles listed on BioPortfolio]

Cedars-Sinai Healthcare Accelerator Unveils Third Class of 10 Digital Health Startups

Techstars Healthcare Accelerator, in partnership with Cedars-Sinai, today announced the 10 digital health startups selected to participate in its third class. From artificial intelligence to new devic...

Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups

Genomics startups are increasing in number and quality, so much so that three-year-old Illumina Accelerator has expanded with its latest class to accommodate five of them. Xconomy got an early look at...

Health Wildcatters Unveils Fifth Class of 9 Health IT Startups

Health Wildcatters, a mentorship-driven healthcare seed accelerator has unveiled nine new health IT companies selected to participate in the 2017 accelerator program. With the addition of these 10 hea...

Health-tech startups get accelerator class to speed ideas and solutions to healthcare marketplace

Cedars-Sinai today launched its third health-tech accelerator class with 10 startups whose innovative technologies aim to transform the delivery and quality of healthcare.

Latest Class of Digital Health Startups Debuts at TMCx Accelerator

Houston—Around 600 entrepreneurs, investors, and others from Houston’s venture and healthcare communities turned out for the TMCx accelerator’s digital health demo day Thursday—many fo...

Health-tech startups expanding innovations one year after completing Cedars-Sinai Accelerator program

One year after graduating from the Cedars-Sinai Accelerator powered by Techstars, several health-tech startups are swiftly expanding their innovations into hospitals and other healthcare settings for ...

Cliexa selected as one of 7 healthcare startups at Venture Hall Accelerator Summer Program in Portland, ME

Portland startup accelerator Venture Hall announced Thursday that seven companies from across the country have been selected for the inaugural class of its summer accelerator program offered in pa...

Top lab CERN launches key new accelerator

Europe's top physics lab CERN launched its newest particle accelerator on Tuesday, billed as a key step towards future experiments that could unlock the universe's greatest mysteries. The Linac 4 acc...

PubMed Articles [5542 Associated PubMed Articles listed on BioPortfolio]

Preliminary Determination of Activation Products for a Varian Truebeam Linear Accelerator.

Medical linear accelerators used to treat various forms of cancers are operated at a number of different energies. A by-product of the high-energy photons produced by accelerators is activation of com...

A single-source photon source model of a linear accelerator for Monte Carlo dose calculation.

To introduce a new method of deriving a virtual source model (VSM) of a linear accelerator photon beam from a phase space file (PSF) for Monte Carlo (MC) dose calculation.

Investigation of (123)I production using electron accelerator.

The possibility of (123)I isotope production with the help of the high-intensity bremsstrahlung photons produced by the electron beam of the LUE50 linear electron accelerator at the A.I. Alikhanyan Na...

Ethnic differences in association of high body mass index with early onset of Type 1 diabetes - Arab ethnicity as case study.

The "accelerator hypothesis" predicts early onset of Type 1 diabetes (T1D) in heavier children. Studies testing direction of correlation between body mass index (BMI) and age at onset of T1D in differ...

Estimation of Airborne Radioactivity Induced By 8-Gev-Class Electron Linac Accelerator.

Airborne radioactivity induced by high-energy electrons from 6 to 10 GeV is estimated by using analytical methods and the Monte Carlo codes PHITS and FLUKA. Measurements using a gas monitor with a NaI...

Clinical Trials [2340 Associated Clinical Trials listed on BioPortfolio]

First-In Man (FIM) Study MR-Linac

Investigational device is the Magnetic resonance imager linear accelerator. Five (5) patients with bone metastases will be treated with palliative intention in this study. The goal is to c...

Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder

The aim of this study is to evaluate, through a pilot study with about ten cases, if bilateral ventral capsulotomy by linear accelerator enable modification of obsessive-compulsive symptom...

Stereotactic Body Radio Therapy (SBRT) for Early-Stage Non Small Cell Lung Cancer (NSCLC)

The purpose of this study is to evaluate local disease control after 2 years in patients with non-metastatic, non-operated non-small-cell lung cancer treated by radiotherapy. Eligible pat...

Autoimmune Diabetes Accelerator Prevention Trial

The autoimmune diabetes ACCELERATOR PREVENTION TRIAL (adAPT) is based on the accelerator hypothesis. The trial is designed to establish whether metformin, an oral hypoglycaemic agent that ...

Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer

This study will assess the efficacy of treating locally advanced pancreatic cancer using a linear accelerator designed for image-guided radiotherapy

Companies [1749 Associated Companies listed on BioPortfolio]

AgTech Accelerator

AgTech Accelerator, established in 2016 in Research Triangle Park, is a venture development organization focused on discovering and developing emerging agricultural technology and...

Cydan

Cydan is an orphan drug accelerator that identifies and de-risks assets with therapeutic and commercial potential. The accelerator’s model evaluates programs for treating rar...

Triphase Accelerator Corporation

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to adva...

SKTA Innopartners

SKTA Innovation Accelerator is a different kind of accelerator based in Silicon Valley. We seed core technology startups by matching entrepreneurs with Strategic Partners committe...

Cydan, LLC

Cydan is an orphan drug accelerator that identifies and de-risks assets with therapeutic and commercial potential. The accelerator’s model evaluates programs for treating rar...

More Information about "Health 2.0 Accelerator" on BioPortfolio

We have published hundreds of Health 2.0 Accelerator news stories on BioPortfolio along with dozens of Health 2.0 Accelerator Clinical Trials and PubMed Articles about Health 2.0 Accelerator for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Health 2.0 Accelerator Companies in our database. You can also find out about relevant Health 2.0 Accelerator Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record